Middle East & Africa Gastric Cancer Diagnostic Procedure Market

The Middle East & Africa gastric cancer diagnostic procedure market was valued at US$ 39.63 million in 2022 to US$ 51.05 million by 2028. It is estimated to grow at a CAGR of 4.3 % from 2022 to 2028.

Rising Awareness of Gastric Cancer Boosts Middle East & Africa Gastric Cancer Diagnostic Procedure Market

Hope For Stomach Cancer is another nonprofit organization that offers resources to patients, caregivers, and loved ones while promoting early detection and prevention in different communities (including medical and nonmedical). The organization develops and rolls out programs to assist stomach cancer patients to live the best possible life throughout the phases of the disease. Therefore, a rising number of gastric cancer awareness programs are expected to offer lucrative opportunities for the Middle East & Africa gastric cancer diagnostic procedures market during the forecast period.

Middle East & Africa Gastric Cancer Diagnostic Procedure Market Overview

The Middle East & Africa gastric cancer diagnostic procedure market is segmented into the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa. Countries in this region report varied incidences of gastric cancer. According to the latest WHO data published in 2020, deaths caused due to stomach cancer reached 389 or 0.29% of total deaths in Saudi Arabia. Moreover, Dyspepsia, a type of gastrointestinal disease, is common across the country. Saudi Arabia records the highest prevalence of dyspepsia in the Gulf, which can potentially lead to more GI complications, poor health, and deteriorating national outcomes. According to an article published in 2019 by Saudi Journal of Gastroenterology, the prevalence rate of H. pylori in Saudi Arabia was reported to be in the range of 50–80% among symptomatic patients with dyspepsia and abdominal pain or in patients undergoing endoscopic procedures. According to an article published in 2021, the prevalence of H. pylori in Saudi Arabia was 71.33% in patients suffering from different biopsy-proven GI conditions, such as gastritis, peptic ulcer disease, and gastric cancer. An upsurge in the number of gastric/stomach cancer, ulcer disease, and GI condition cases favors the overall growth of the gastric cancer diagnostic procedure market.

Middle East & Africa Gastric Cancer Diagnostic Procedure Market Revenue And Forecast To 2028 (US$ Million)

Middle East & Africa Gastric Cancer Diagnostic Procedure Strategic Insights

Strategic insights for the Middle East & Africa Gastric Cancer Diagnostic Procedure provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Middle East & Africa Gastric Cancer Diagnostic Procedure Report Scope

Middle East & Africa Gastric Cancer Diagnostic Procedure Regional Insights

The geographic scope of the Middle East & Africa Gastric Cancer Diagnostic Procedure refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

Middle East & Africa Gastric Cancer Diagnostic Procedure Market Segmentation

The Middle East & Africa gastric cancer diagnostic procedure market is segmented into healthcare providers, symptom types, body fluid, procedures, offerings, disease indication, and country.

Based on healthcare providers, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into diagnostic laboratories, hospitals, cancer research institutes, oncology specialty clinics, and others. The Hospitals segment held the largest gastric cancer diagnostic procedure market share in 2022.

Based on symptoms type, the South & Central America gastric cancer diagnostic procedure market is segmented into symptomatic and asymptomatic. The Asymptomatic segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on body fluid, The Middle East & Africa gastric cancer diagnostic procedure market is segmented into Blood, urine, saliva, stomach wash/gastric juice, tissue and others. Blood segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on offering, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into Instruments, Reagents & Consumables and Services. Reagents & Consumables segment held the Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on Diagnostic procedure, the Middle East & Africa gastric cancer diagnostic procedure market is categorized into Endoscopic procedure, Biopsy and tissue tests, lab test, In-vitro diagnostic tests, Imaging Test, Molecular Diagnostics, Multiplexing molecular Diagnostics, Immunoassay, and others. The imaging segment held largest Middle East & Africa gastric cancer diagnostic procedure market share in 2022. 

Based on disease condition, the Middle East & Africa gastric cancer diagnostic procedure market is segmented into Early Gastric cancer and Gastric cancer advanced types. The Gastric cancer advanced type segment held larger Middle East & Africa gastric cancer diagnostic procedure market share in 2022.

Based on country, the Middle East & Africa gastric cancer diagnostic procedure market has been segmented into Saudi Arabia, South Africa, the UAE, and Rest of the Middle East & Africa. Saudi Arabia dominated the market in this region in 2022.  

Bio-Rad Laboratories Inc; F. Hoffmann-La Roche Ltd; bioMerieux SA; Thermo Fisher Scientific Inc; Illumina Inc; and Vela Diagnostics Holding Pte Ltd. are the leading companies operating in the Middle East & Africa gastric cancer diagnostic procedure market.